A61P 1/04

Sub-Class

Watch 9Status Updates

Stats

Description

Class  A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS


Subclass 1/04: Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Recent Patents

Patent #TitleFiling DateIssue DatePatent Owner
11992497 Cannabinoid derivatives and their useApr 12, 23May 28, 24DEMEETRA AGBIO, INC.
11992533 Methods of treatment of HLA-B27 related inflammatory diseases and compositions related to sameFeb 16, 22May 28, 24Not available
11959067 Bifidobacterium lactis strain for preventing or treating colitis and method for preventing or alleviating colitisAug 31, 22Apr 16, 24HARBIN SUNFLOWER PHARMACEUTICAL CO., LTD.
11925688 Compositions and methods relating to salts of specialized pro-resolving mediatorsOct 01, 21Mar 12, 24Thetis Pharmaceuticals LLC
11911441 Methods of use of CD24 for the prevention and treatment of leukemia relapseJun 03, 19Feb 27, 24Oncoimmune, Inc.; The University of Maryland Baltimore;
11896564 Medical treatment for pathologic inflammationAug 15, 19Feb 13, 24PHARMACYL AB
11896569 Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapyOct 29, 21Feb 13, 24Professional Dietetics S.P.A.
11896609 Pharmaceutical composition for treating inflammatory diseases comprising germanium telluride nanosheets coated with polyvinylpyrrolidoneAug 23, 22Feb 13, 24Industry-Academic Cooperation Foundation
11897848 Crystalline forms of ozanimod and processes for preparation thereofJun 04, 21Feb 13, 24RECEPTOS LLC
11891383 Crystalline salts of peptide epoxyketone immunoproteasome inhibitorSep 27, 22Feb 06, 24KEZAR LIFE SCIENCES
11891440 Antibodies with improved stability to intestinal digestion, polynucleotides thereof and methods of use thereof to treat diseaseSep 29, 16Feb 06, 24CIRCLE33 LLC
11871767 Microbial compositions and methods for ruminant health and performanceJun 22, 21Jan 16, 24Native Microbials, Inc.
11873287 Piperidine-2,6-dione derivatives and ulcerative colitis treatingJun 03, 22Jan 16, 24Tianjin Hemay Pharmaceutical Sci-Tech Co., Ltd; Ganzhou Hemay Pharmaceutical, Co., Ltd;
11866503 Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptorSep 22, 20Jan 09, 24Regeneron Pharmaceuticals, Inc.
11865133 Pharmaceutical composition comprising organoid and anti-inflammatory agent for preventing or treating inflammatory bowel diseaseSep 16, 22Jan 09, 24ORGANOIDSCIENCES LTD.
11857510 Methods and compositions for treating congenital diarrhea disorderMay 31, 18Jan 02, 24NAPO PHARMACEUTICALS, INC.
11851429 AMPK activatorsJan 26, 22Dec 26, 23KALLYOPE, INC.
11851449 Heterocyclic amide compounds having an RORvt inhibitory actionMay 10, 21Dec 26, 23Takeda Pharmaceutical Company Limited
11839633 Composition and method of treating gastrointestinal disease with microbial and soy mixtureMar 17, 20Dec 12, 23SVK Herbal Corporation
11833159 Non-hormonal steroid modulators of NF-kB for treatment of diseaseOct 28, 20Dec 05, 23ReveraGen BioPharma, Inc.

more results

Recent Publications

Publication #TitleFiling DatePub DatePatent Owner
2024/0173,365 METHODS OF COLONIZING A MICROBIOME, TREATING AND/OR PREVENTING INFLAMMATORY BOWEL DISEASE AND GRAFT VERSUS HOST DISEASEJun 28, 22May 30, 24Vedanta Biosciences, Inc.
2024/0174,688 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITYOct 05, 23May 30, 24Not available
2024/0165,170 USE OF LACTIC ACID BACTERIUM SET FOR PREVENTING OR TREATING NSAID-INDUCED GASTRIC ULCERMar 06, 23May 23, 24GRAPE KING BIO LTD.
2024/0166,601 NLRX1 LIGANDSJun 19, 23May 23, 24LANDOS BIOPHARMA, INC.
2024/0156,880 BACTERIOTHERAPYAug 09, 23May 16, 24Not available
2024/0148,767 THE USE OF EMPAGLIFLOZIN FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASEMar 03, 22May 09, 24Not available
2024/0150,424 DIRECTED CHEMICAL CONJUGATE OF GLUCAGON-LIKE PEPTIDE-2 MUTANT, AND USE THEREOFJan 19, 24May 09, 24PEG-BIO BIOPHARM CO.,LTD.(CHONGQING)
2024/0139,235 IRON(III) FORMULATIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATIONMar 14, 22May 02, 24Not available
2024/0131,057 PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES COMPRISING GERMANIUM TELLURIDE NANOSHEETS COATED WITH POLYVINYLPYRROLIDONEDec 28, 23Apr 25, 24Not available
2024/0131,082 Compositions and Methods for Delivering a Bacterial Metabolite to a SubjectOct 18, 20Apr 25, 24Finch Therapeutics Holdings LLC
2024/0132,466 PIPERIDINE-2,6-DIONE DERIVATIVES AND ULCERATIVE COLITIS TREATINGDec 08, 23Apr 25, 24Not available
2024/0132,601 ANTI-MET ANTIBODIES AND USES THEREOFDec 13, 23Apr 25, 24Not available
2024/0115,644 COMPOSITION FOR PREVENTING, IMPROVING OR TREATING GASTRITIS OR PEPTIC ULCER COMPRISING EXTRACT OF CINNAMOMUM CASSIA, FRACTION OF SAID EXTRACT, ISOLATE OF SAID FRACTION OR COMPOUNDS ISOLATED THEREFROMDec 23, 21Apr 11, 24Not available
2024/0108,647 FORMULATIONS FOR TREATING ACID REFLUX COMPRISING SODIUM ALGINATEDec 13, 23Apr 04, 24Not available
2024/0101,558 AMPK ACTIVATORSNov 01, 23Mar 28, 24Not available
2024/0091,306 PEPTIDES ENDOWED WITH ANGIOGENIC ACTIVITYSep 06, 21Mar 21, 24Not available
2024/0081,382 COMPOSITION FOR IMPROVING INTESTINAL FLORANov 20, 23Mar 14, 24Not available
2024/0076,296 THIAZOLE DERIVATIVES FOR THERAPEUTIC USEAug 21, 23Mar 07, 24NIMML INSTITUTE
2024/0076,323 PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERSJul 18, 23Mar 07, 24Not available
2024/0066,049 NEW COMBINATIONS AND COMPOSITIONS OF SUCRALFATE IN ALGINATE AND THEIR USE IN THERAPYDec 30, 21Feb 29, 24Not available

more results

Top Owners in This Subclass

Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More

Patents Issued To Date - By Filing Year

Average Time to Issuance